TIA is a medical emergency — the 90-day stroke risk can be as high as 17.8%, with nearly half of strokes occurring within the first 2 days of the index event. [3-4] Prompt evaluation and initiation of secondary prevention can reduce the 3-month stroke risk by up to 80%. [4]
1. History
- Onset: Abrupt onset of focal neurological symptoms — motor (hemiparesis), sensory (hemisensory loss), visual (amaurosis fugax, hemianopia), or speech (aphasia, dysarthria) [3-4]
- Duration: Symptoms typically last seconds to minutes, usually <1 hour; linear increase in likelihood of infarction with increasing duration [3-4]
- Timing: Exact time of onset is critical — determines eligibility for DAPT and guides urgency of workup
- Progression: Symptoms should be maximal at onset (not marching/spreading); complete resolution to baseline is required for TIA diagnosis [3][5]
- Associated symptoms: Ask about palpitations (AF), chest pain (concurrent ACS), headache (may suggest mimic or dissection)
- Important negatives: Absence of seizure activity, no preceding aura with gradual spread, no loss of consciousness, no confusion/encephalopathy [3-4]
- Recurrence: Ask about prior TIA episodes in the past 7 days — dual/crescendo TIA is a high-risk feature warranting admission [3]
2. Alarm Features
- Crescendo TIA: Recurrent events with increasing duration, frequency, or severity — suggests ipsilateral carotid stenosis [3]
- Persistent or fluctuating deficits: May represent evolving stroke rather than TIA
- High ABCD2 score (≥4): Associated with 90-day stroke risk of 9.8–17.8% [3][6]
- New atrial fibrillation on ECG [3]
- Symptomatic carotid stenosis >50% on vascular imaging [3]
- DWI-positive lesion on MRI: Reclassifies as ischemic stroke; >6-fold increased risk of recurrent stroke at 1 year [3]
- Severe uncontrolled hypertension at presentation [3][7]
3. Medications
Acute treatment:
- Aspirin 162–325 mg loading dose immediately, followed by 81 mg daily [3-4]
- DAPT for high-risk TIA (ABCD2 ≥4): Aspirin + clopidogrel (300 mg load, then 75 mg daily) for 21 days, then transition to single antiplatelet therapy [8-9]
- Alternative DAPT: Aspirin + ticagrelor (180 mg load, then 90 mg BID) for 30 days — FDA-approved for high-risk TIA, though associated with increased bleeding risk [8][10]
Secondary prevention:
- Antihypertensives: Goal BP <130/80 mmHg; ACE inhibitors, ARBs, or thiazide diuretics preferred [3]
- High-intensity statin: Goal LDL <70 mg/dL; atorvastatin 40–80 mg or rosuvastatin [3]
- Anticoagulation if AF detected: DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) preferred over warfarin [3][10]
Contraindicated/cautions:
- Do NOT use anticoagulation for noncardioembolic TIA — no benefit over aspirin and increased bleeding [4][9]
- Long-term DAPT (>90 days) is NOT recommended — increased bleeding without additional benefit [9]
- Triple antiplatelet therapy (aspirin + clopidogrel + dipyridamole) is not recommended [9]
4. Diet
- Mediterranean diet: Recommended by AHA/ASA; associated with 40% reduction in stroke risk in the PREDIMED trial (HR 0.60) [8-9]
- DASH diet: Emphasizes fruits, vegetables, whole grains, low-fat dairy; limits sodium, saturated fat, and processed foods [9]
- Sodium restriction: <2.3 g/day; a 1 g/day reduction in sodium is associated with a 20% reduction in cardiovascular events [9][11]
- Limit alcohol: ≤2 drinks/day for men, ≤1 for women [9][12]
- Avoid: High-fat, fried foods, processed meats, sugar-sweetened beverages — associated with increased stroke risk [9][12]
- For diabetic patients, consider referral to a nutrition specialist [3]
5. Review of Systems
- Neurological: Weakness, numbness, speech difficulty, vision changes, gait instability, vertigo, diplopia
- Cardiovascular: Palpitations (AF), chest pain (concurrent ACS), dyspnea
- Ophthalmologic: Monocular vision loss (amaurosis fugax — retinal ischemia) vs. binocular field cut (cerebral ischemia) [4]
- Constitutional: Headache (dissection, GCA), jaw claudication, scalp tenderness (GCA in patients >50 with visual symptoms) [3]
- Psychiatric/functional: Screen for anxiety, depression, functional overlay
6. Collateral History and Family History
- Witness accounts are critical — patients may not recall exact symptom details or duration; bystanders can confirm abrupt onset and resolution
- Family history: Premature cardiovascular disease, stroke, AF, hypercoagulable states, sickle cell disease
- Social context: Smoking status, alcohol/substance use (cocaine, amphetamines), medication compliance, ability to follow up, transportation barriers [3]
7. Risk Factors
The most prevalent comorbidities among TIA patients include: [13-14]
- Hypertension (~56%) — the most potent modifiable risk factor (PAF 19.3%)
- Diabetes mellitus (~22%) — PAF 7.7%
- Atrial fibrillation (~14%) — PAF 3.8%, but strokes tend to be larger and more disabling [15]
- Dyslipidemia (~17%)
- Large artery atherosclerosis (~19%) — including carotid stenosis
- Prior stroke/TIA — PAF 12.0%
- Smoking — PAF 11.2%
- Ischemic heart disease — PAF 10.7%
- Obesity, physical inactivity, obstructive sleep apnea [3]
8. Differential Diagnosis
Approximately 1 in 5 patients presenting with suspected TIA has a TIA mimic. [16] Up to 60% of initial TIA diagnoses may ultimately be reclassified. [17]
Cannot-miss diagnoses:
- Acute ischemic stroke (persistent deficits or DWI-positive on MRI)
- Intracranial hemorrhage (subarachnoid, subdural, intracerebral)
- Cervical artery dissection (neck pain, Horner syndrome, young patient)
- Hypoglycemia — always check point-of-care glucose [3]
Common mimics:
- Migraine with aura: Gradual spread of symptoms ("march"), positive phenomena (scintillations, tingling), headache follows within 1 hour; younger patients [4-5]
- Seizure/postictal (Todd's) paralysis: Symptoms march from site of onset, may have witnessed convulsive activity; more common mimic in elderly [18]
- Peripheral vertigo (BPPV, vestibular neuritis): Isolated vertigo/dizziness without other focal findings [4]
- Transient global amnesia: Isolated memory loss without other focal deficits [4]
- Syncope/presyncope: Loss of consciousness, not focal
- Functional neurological disorder: Inconsistent exam findings
- Internal medicine diseases (metabolic derangements, infections): More common mimics in elderly patients [18]
Distinguishing features favoring TIA: Abrupt onset, unilateral weakness, facial palsy, dysarthria, older age with vascular risk factors [16][18]
9. Past Medical History
- Prior stroke or TIA (strongest predictor of recurrence) [14]
- Atrial fibrillation, valvular heart disease, recent MI, cardiomyopathy
- Carotid stenosis or peripheral artery disease
- Hypertension, diabetes, hyperlipidemia
- Hypercoagulable states, sickle cell disease
- History of migraine (may confound diagnosis)
- Surgical history: Prior carotid endarterectomy/stenting, cardiac surgery
- Current medications: Antiplatelet/anticoagulant use, antihypertensives, statins
10. Physical Exam
- Vitals: Blood pressure in both arms (asymmetry may suggest subclavian steal or dissection), heart rate and rhythm (irregular → AF), oxygen saturation
- Complete neurological exam: Must be at baseline for TIA diagnosis — any persistent deficit suggests stroke [3]
- Cranial nerves (facial droop, visual fields, extraocular movements)
- Motor strength (drift testing)
- Sensation, coordination, gait
- Language (naming, repetition, comprehension)
- Cardiovascular: Carotid bruits, cardiac murmurs, irregular rhythm
- Fundoscopic exam: Hollenhorst plaques (cholesterol emboli) in amaurosis fugax
- HINTS exam: If posterior circulation symptoms (vertigo, diplopia) — to differentiate central from peripheral vertigo
11. Lab Studies
Mandatory: [3]
- Point-of-care glucose — rule out hypoglycemia (stroke mimic)
- CBC — thrombocytosis, polycythemia, anemia
- BMP/CMP — electrolytes, renal function (baseline before CTA contrast)
- HbA1c — identify undiagnosed/uncontrolled diabetes
- Fasting or nonfasting lipid panel [3]
- Troponin — concurrent ACS shares risk factors with TIA [3]
- Coagulation studies (PT/INR) — if on anticoagulation or considering anticoagulation
Selective:
- ESR and CRP in patients >50 with visual complaints → rule out giant cell arteritis [3]
- Toxicology screen if substance use suspected
- Hypercoagulability workup in young patients without traditional risk factors
12. Imaging
Brain imaging:
- NCCT head: First-line in ED; low sensitivity for acute ischemia (~4%) but rules out hemorrhage, mass lesion, and other mimics [3][6]
- MRI with DWI: Gold standard — 88% sensitivity, 95% specificity for acute infarction within 24 hours; should be obtained ideally within 24 hours of symptom onset. DWI-positive lesions found in ~34–40% of clinically diagnosed TIA [3][6]
- If MRI with DWI is immediately available, NCCT can be safely skipped in stable patients with resolved symptoms [3]
Vascular imaging:
- CTA head and neck: Most widely accessible in ED; high sensitivity for extracranial and intracranial stenosis; can be obtained simultaneously with NCCT. Safe in chronic kidney disease [3]
- MRA: Alternative if contrast is a concern; gadolinium-enhanced MRA preferred over time-of-flight (which overestimates stenosis) [3]
- Carotid duplex ultrasound: Noninvasive option but may not be available in ED [3]
- Digital subtraction angiography: Gold standard for vasculature but invasive — not for screening [3]
When imaging is unnecessary: Imaging should NOT be deferred — vascular imaging is warranted regardless of ABCD2 score [3]
13. Special Tests
Risk stratification scores:
The ABCD2 score is the most widely used tool for TIA risk stratification: [3][6]
Cardiac monitoring:
- 12-lead ECG on all patients — detects AF in up to 7% [3][9]
- Telemetry during ED stay/observation
- Prolonged cardiac monitoring (30 days) if cardioembolic source suspected and no AF on initial ECG — recommended within 6 months of event [3]
- Transthoracic echocardiogram: If cardioembolic source suspected; can be arranged as expedited outpatient study within 1 week if low suspicion [3]
- Transesophageal echocardiogram/bubble study: For PFO evaluation in cryptogenic events, especially in younger patients
14. ECG
- Obtain on ALL patients with suspected TIA [3][9]
- Atrial fibrillation/flutter: Most important finding — changes management from antiplatelet to anticoagulation [3]
- Left ventricular hypertrophy: Suggests chronic hypertension
- ST changes/Q waves: May indicate concurrent or prior MI
- Prolonged QTc, bundle branch blocks: Structural heart disease markers
- If initial ECG is normal but cardioembolic source is suspected, prolonged rhythm monitoring is indicated [3-4]
15. Assessment
TIA is defined as an acute neurovascular syndrome with focal neurological symptoms attributable to a vascular territory that rapidly resolves, with no evidence of infarction on DWI MRI. [3] If DWI is positive, the diagnosis is reclassified as ischemic stroke regardless of symptom duration. [3]
Severity stratification (by ABCD2 score): [3][6]
- Low risk (0–3): 2-day stroke risk ~1.0%, 90-day risk ~3.1%
- Moderate risk (4–5): 2-day risk ~4.1%, 90-day risk ~9.8%
- High risk (6–7): 2-day risk ~8.1%, 90-day risk ~17.8%
However, ABCD2 alone has limitations — it does not capture posterior circulation symptoms, carotid stenosis, or AF. Vessel imaging and cardiac evaluation should supplement clinical scoring. [3-4]
Complications to consider: Recurrent TIA, completed stroke, hemorrhagic transformation (if anticoagulated), carotid dissection progression.
16. Treatment Plan
The following algorithm from JAMA summarizes the management approach:
Initial stabilization:
- ABCs, IV access, continuous monitoring
- Point-of-care glucose — treat hypoglycemia immediately
- Permissive hypertension acutely (avoid aggressive BP lowering that could worsen hypoperfusion, especially with suspected large vessel stenosis) [3]
Antiplatelet therapy (start within 12–24 hours of symptom onset): [3][8]
Long-term secondary prevention: [3][8-9]
- BP goal <130/80 mmHg: ACEi/ARB + thiazide preferred
- LDL goal <70 mg/dL: High-intensity statin ± ezetimibe ± PCSK9 inhibitor
- Glycemic control: HbA1c optimization
- Smoking cessation: Counseling + pharmacotherapy (varenicline, bupropion, NRT)
- Carotid endarterectomy/stenting: For symptomatic carotid stenosis ≥50% (ideally within 2 weeks) [4][9]
17. Disposition
Admit if: [3]
- High ABCD2 score (≥4–6, depending on institutional protocol)
- DWI-positive lesion on MRI (reclassified as stroke)
- Symptomatic carotid or intracranial stenosis >50%
- New atrial fibrillation
- Crescendo or dual TIA
- Severe uncontrolled hypertension or metabolic derangements
- Inability to complete workup or arrange timely follow-up
- Social barriers (lack of transportation, unreliable follow-up)
Discharge with rapid outpatient follow-up if: [3][20]
- Low ABCD2 score (0–3)
- Normal brain and vascular imaging
- No AF on ECG
- Reliable follow-up available (TIA clinic within 48 hours, neurology within 1 week)
- Secondary prevention initiated in ED
- Patient understands return precautions
Observation (24-hour unit):
- Intermediate-risk patients awaiting MRI or vascular imaging
- Patients who need cardiac monitoring but do not meet full admission criteria
Outpatient TIA clinic management is noninferior to inpatient care when rapid protocols are in place, and is associated with significant cost savings. [3][20] However, patients discharged from the ED without assigned follow-up have an increased risk of subsequent stroke. [20]
18. Follow Up / Return Precautions
Follow-up timing:
- Neurology/TIA clinic: Ideally within 48 hours, no later than 1 week [3]
- Primary care: Within 1–2 weeks for risk factor optimization
- Outpatient MRI: If not obtained acutely, ideally within 24 hours [3]
- Outpatient echocardiogram: Within 1 week if not done inpatient [3]
- Prolonged cardiac monitoring: Arrange within 6 months if cardioembolic source suspected [3]
- Transition DAPT to monotherapy at 21 days (coordinate with neurology) [8]
Return precautions — instruct patients to call 911 immediately for:
- Any new or recurrent weakness, numbness, or facial droop
- New speech difficulty or confusion
- New vision loss or visual field changes
- Severe headache unlike any prior headache
- New difficulty walking or loss of coordination
- Any symptom that does not resolve within minutes
Patient counseling:
- TIA is a warning stroke — the risk of a completed stroke is highest in the first 48 hours
- Medication adherence is critical — do not stop aspirin, clopidogrel, or statin without physician guidance
- Lifestyle modifications (diet, exercise, smoking cessation) significantly reduce recurrence risk [3][8-9]
- Expected recovery: Symptoms of TIA itself should be fully resolved; focus is on preventing future events
References
1. Performance of the ABCD2 Score for Stroke Risk Post TIA: Meta-Analysis and Probability Modeling. — Sanders LM, Srikanth VK, Blacker DJ, et al. Neurology. 2012.
2. Performance of the ABCD2 Score for Stroke Risk Post TIA: Meta-Analysis and Probability Modeling. — Sanders LM, Srikanth VK, Blacker DJ, et al. Neurology. 2012.
3. Performance of the ABCD2 Score for Stroke Risk Post TIA: Meta-Analysis and Probability Modeling. — Sanders LM, Srikanth VK, Blacker DJ, et al. Neurology. 2012.
4. Multicenter External Validation of the ABCD2 Score in Triaging TIA Patients. — Tsivgoulis G, Stamboulis E, Sharma VK, et al. Neurology. 2010.
5. Multicenter External Validation of the ABCD2 Score in Triaging TIA Patients. — Tsivgoulis G, Stamboulis E, Sharma VK, et al. Neurology. 2010.
6. Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting: A Scientific Statement From the American Heart Association. — Amin HP, Madsen TE, Bravata DM, et al. Stroke. 2023.
7. Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting: A Scientific Statement From the American Heart Association. — Amin HP, Madsen TE, Bravata DM, et al. Stroke. 2023.
8. Transient Ischemic Attack. — Amarenco P. The New England Journal of Medicine. 2020.
9. Transient Ischemic Attack. — Amarenco P. The New England Journal of Medicine. 2020.
10. Migraine in Older Adults. — Hugger SS, Do TP, Ashina H, et al. The Lancet. Neurology. 2023.
11. Migraine in Older Adults. — Hugger SS, Do TP, Ashina H, et al. The Lancet. Neurology. 2023.
12. Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review. — Mendelson SJ, Prabhakaran S. The Journal of the American Medical Association. 2021.
13. Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review. — Mendelson SJ, Prabhakaran S. The Journal of the American Medical Association. 2021.
14. A Prospective Cohort Study of Patients With Transient Ischemic Attack to Identify High-Risk Clinical Characteristics. — Perry JJ, Sharma M, Sivilotti ML, et al. Stroke. 2014.
15. A Prospective Cohort Study of Patients With Transient Ischemic Attack to Identify High-Risk Clinical Characteristics. — Perry JJ, Sharma M, Sivilotti ML, et al. Stroke. 2014.
16. Secondary Prevention after Ischemic Stroke. — Furie KL, Kelly PJ. The New England Journal of Medicine. 2026.
17. Secondary Prevention after Ischemic Stroke. — Furie KL, Kelly PJ. The New England Journal of Medicine. 2026.
18. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. — Kleindorfer DO, Towfighi A, Chaturvedi S, et al. Stroke. 2021.
19. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. — Kleindorfer DO, Towfighi A, Chaturvedi S, et al. Stroke. 2021.
20. FDA Orange Book. — FDA Orange Book. 2026.
21. FDA Orange Book. — FDA Orange Book. 2026.
22. Secondary Prevention of Ischemic Stroke: Updated Guidelines From AHA/ASA. — Ford B, Peela S, Roberts C. American Family Physician. 2022.
23. Secondary Prevention of Ischemic Stroke: Updated Guidelines From AHA/ASA. — Ford B, Peela S, Roberts C. American Family Physician. 2022.
24. Ischemic Stroke Management: Posthospitalization and Transition of Care. — Larson ST, Ray BE, Wilbur J. American Family Physician. 2023.
25. Ischemic Stroke Management: Posthospitalization and Transition of Care. — Larson ST, Ray BE, Wilbur J. American Family Physician. 2023.
26. A 5-Decade Analysis of Incidence Trends of Ischemic Stroke After Transient Ischemic Attack: A Systematic Review and Meta-analysis. — Shahjouei S, Sadighi A, Chaudhary D, et al. JAMA Neurology. 2021.
27. A 5-Decade Analysis of Incidence Trends of Ischemic Stroke After Transient Ischemic Attack: A Systematic Review and Meta-analysis. — Shahjouei S, Sadighi A, Chaudhary D, et al. JAMA Neurology. 2021.
28. Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis. — Khan F, Yogendrakumar V, Lun R, et al. Circulation. 2026.
29. Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis. — Khan F, Yogendrakumar V, Lun R, et al. Circulation. 2026.
30. Stroke. — Campbell BCV, Khatri P. Lancet. 2020.
31. Stroke. — Campbell BCV, Khatri P. Lancet. 2020.
32. Transient Ischemic Attack Versus Transient Ischemic Attack Mimics: Frequency, Clinical Characteristics and Outcome. — Amort M, Fluri F, Schäfer J, et al. Cerebrovascular Diseases. 2011.
33. Transient Ischemic Attack Versus Transient Ischemic Attack Mimics: Frequency, Clinical Characteristics and Outcome. — Amort M, Fluri F, Schäfer J, et al. Cerebrovascular Diseases. 2011.
34. Clinical Policy: Critical Issues in the Evaluation of Adult Patients With Suspected Transient Ischemic Attack in the Emergency Department. — Lo BM, Carpenter CR, Hatten BW, Wright BJ, Brown MD. Annals of Emergency Medicine. 2016.
35. Clinical Policy: Critical Issues in the Evaluation of Adult Patients With Suspected Transient Ischemic Attack in the Emergency Department. — Lo BM, Carpenter CR, Hatten BW, Wright BJ, Brown MD. Annals of Emergency Medicine. 2016.
36. Age-Dependent Differences in the Rate and Symptoms of TIA Mimics in Patients Presenting With a Suspected TIA to a Neurological Emergency Room. — Ippen FM, Walter F, Hametner C, et al. Frontiers in Neurology. 2021.
37. Age-Dependent Differences in the Rate and Symptoms of TIA Mimics in Patients Presenting With a Suspected TIA to a Neurological Emergency Room. — Ippen FM, Walter F, Hametner C, et al. Frontiers in Neurology. 2021.
38. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke. — Amarenco P, Lavallée PC, Labreuche J, et al. The New England Journal of Medicine. 2016.
39. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke. — Amarenco P, Lavallée PC, Labreuche J, et al. The New England Journal of Medicine. 2016.
40. Risk of Subsequent Stroke Among Patients Receiving Outpatient vs Inpatient Care for Transient Ischemic Attack: A Systematic Review and Meta-analysis. — Shahjouei S, Li J, Koza E, et al. JAMA Network Open. 2022.
41. Risk of Subsequent Stroke Among Patients Receiving Outpatient vs Inpatient Care for Transient Ischemic Attack: A Systematic Review and Meta-analysis. — Shahjouei S, Li J, Koza E, et al. JAMA Network Open. 2022.